Browsing by Author "Olumade, T. J."

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
    (Nature Portfolio, 2023-02) Olawoye, I. B.; Oluniyi, P. E.; Oguzie, J. U.; Uwanibe, J. N.; Kayode, T. A.; Olumade, T. J.; Ajogbasile, F. V.; Parker, E.; Eromon, P. E.; Abechi, P.; Fowotade, A.
    Identifying the dissemination patterns and impacts of a virus of economic or health importance during a pandemic is crucial, as it informs the public on policies for containment in order to reduce the spread of the virus. In this study,we integrated genomic and travel data to investigate the emergence and spread of the SARS-CoV-2 B.1.1.318 and B.1.525 (Eta) variants of interest in Nigeria and the wider Africa region. By integrating travel data and phylogeographic reconstructions, we find that these two variants that arose during the second wave in Nigeria emerged from within Africa, with the B.1.525 from Nigeria, and then spread to other parts of the world. Data from this study show how regional connectivity of Nigeria drove the spread of these variants of interest to surrounding countries and those connected by air-traffic. Our findings demonstrate the power of genomic analysis when combined with mobility and epidemiological data to identify the drivers of transmission, as bidirectional transmission within and between African nations are grossly underestimated as seen in our import risk index estimates.
  • Thumbnail Image
    Item
    Prevalence of hepatitis b virus (HBV) basal core promoter/precore region molecular variants among HIV/HBV co-infected and HBV mono-infected patients in Ile-Ife, Nigeria
    (Medwin Publishers, 2021) Osasona, O. G.; Boudarene, L.; Fasoro, O. A.; George, U. E.; Oguzie, J.; Ariyo, O. E.; Olumade, T. J.; Adeniyi, A.; Adewumi, O. M.; Adeniji, J. A
    Introduction: Evolution of phenotypic diversity among viruses occurs as an escape mechanism against host immune pressure or drug selective pressure. Among HIV/HBV co-infected individuals, various HBV basal core promoter (BCP)/precore (PC) region molecular mutants had been reported with associated phenotypic defect in HBeAg production. The emergence of HBeAg negative variants of HBV in HIV co-infected individuals have profound implication on the diagnosis, management and prognosis of this subset of individuals. This includes delayed clearance of HBV, early development of adverse hepatic events such as liver cirrhosis and hepatocellular carcinoma. Currently, little is known about HBV BCP/PC region genomic heterogeneity in HIV/HBV co-infected patients in Nigeria. Therefore, this study was focused on investigating evidence of precore/core region genomic variability among HIV/HBV co-infected patients in Nigeria. Materials and Methods: A total of 40 patients (20 HIV/HBV co-infected and 20 HBV mono-infected samples) were enrolled into the study and subsequently tested for HBsAg, HBeAg and HBeAb using specific Enzyme-Linked Immunosorbent Assay (ELISA). The BCP/PC genome regions (nucleotides 1653-1959) were amplified using a nested PCR assay and then subjected to BCP/PC mutational analysis in genome sites affecting HBeAg expression especially at the BCP transcriptional and PC Translational stop codon sites. Results: Overall, 5 (83.3%) of the six exploitable sequences after analysis showed various BCP/PC mutations. Only 1(16.6%) sequence from an HIV/HBV co-infected patient had the BCP transcriptional (double mutation; A1762T/G1764A) mutant. Analysis of the PC translational stop codon showed 4 (66.6%) having the G1896A mutants while 33.3% (2) had G1899A mutants. Conclusion: This study has broadened the available evidence of BCP/PC region molecular mutants among HIV/HBV coinfected patients in Nigeria and assessed the difference of mutation prevalence in comparison with HBV mono-infected cohort.